Comparing two blood thinners for kidney therapy
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at two different blood thinners—regional citrate and systemic heparin—used during continuous kidney replacement therapy (CKRT) for acute kidney injury (AKI). It aims to learn which works better and safer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older, or a child with a legal guardian's consent
- You have acute kidney injury (AKI) that needs continuous kidney replacement therapy
- Your body weight must be at least 8 kilograms
- Your doctors estimate you will live for more than 3 days
- You cannot have uncontrolled bleeding or blood clotting problems
- You must not be in another interventional study in the last 30 days
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a special blood filtration machine (multiFiltratePRO) in children with kidney failure who need continuous dialysis. It aims to see how well the treatment works and if it's safe for younger patients.
This trial compares two ways to prevent blood clots during a specific type of kidney dialysis called hemodiafiltration. If you have end-stage kidney disease and receive dialysis three times a week, this study may help doctors find the safest anticoagulation method for you.
This study looks at using a blood thinner called citrate during continuous kidney dialysis (renal replacement therapy) in critically ill patients with acute kidney injury. It aims to see if this approach is safe and workable for patients whose bodies may not process citrate normally.
This study tests how safe a specific blood thinner called “citrate” is when used during continuous kidney dialysis (CRRT) for people with AKI or kidney failure. If you qualify, your care team will compare citrate safety against standard approaches to see if it’s tolerable and safe.
This trial compares two types of dialysis (hemodialysis and hemodiafiltration) to see which is better at removing waste from the blood in ICU patients with sudden kidney failure. It may help doctors choose the best treatment for you.
This study tests whether a specific blood-thinning method using citrate works safely and effectively in critically ill patients whose kidneys have suddenly stopped working and need a special filtering machine. Researchers want to confirm that this approach prevents dangerous blood clots while keeping patients safe.
Hear when a new Acute Kidney Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.